Boehringer taps NiceLabel to launch global standardized label process

Drugs prescription pad
NiceLabel’s tools include a built-in document management system that will let Boehringer replace its manual quality control procedures with a digitized quality assurance process. (Getty/Ligorko)

Pharma manufacturer Boehringer Ingelheim has recruited label design and management systems specialist NiceLabel to develop a global standardized labeling process.

The German pharma had previously announced it would adopt a global SAP system in an effort to streamline its global operations. As part of that effort, it brought NiceLabel on board for its label management system.

RELATED: Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

NiceLabel’s tools include a built-in document management system that will let Boehringer replace its manual quality control procedures with a digitized quality assurance process. It will be integrated with Boehringer’s ERP systems, SAP ECC, which will provide a centralized way of updating label information and allow for much faster label change requests.

“It’s great to see how Boehringer Ingelheim is really using the full spectrum of our label management system,” Ken Moir, NiceLabel’s vice president of marketing, said in a statement.

RELATED: Boehringer Ingelheim opens inhaler plant with 200 jobs

Boehringer first introduced the system at its manufacturing sites in Ingelheim, Germany, and Sant Cugat, Spain. The company plans to launch the system at plants in Dortmund, Germany, and Koropi, Greece. Additionally, the system is expected to be used for non-production purposes such as warehouse and quality management.

Suggested Articles

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.